Failed MS Drugs
One often reads a lot about positive study results on certain active ingredients. However, one often hears little later about failed MS active ingredients. Prof. Mathias Mäurer reports in this AMSEL video why this is
Continue readingTag: “Biotin”
High-Dose Biotin is a Dead End
The treatment options for progressive MS are limited – so interest was high when the study data on the use of high-dose biotin in progressive MS was first presented at the American Neurology Congress in
Continue readingNews from the AAN 2015 on PPMS
At the end of April, I had the opportunity to attend the annual meeting of the American Academy of Neurology (AAN) – the largest annual neurological congress where more than 10,000 neurologists and neuroscientists meet.
Continue reading
